ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept

31.10.2022 - Expects to extend cash runway to mid-2025SOUTH SAN FRANCISCO, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) - ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 ... Seite 1

Related Keywords

,Christophera Herr ,Kale Frank ,Silicon Valley Bank ,Senior Managing Director ,Valley Bank ,Life Science ,Silicon Valley ,